2009-08-12 03:07:00 -

Research and Markets ( www.researchandmarkets.com/research/049a01/collagens_clinical : ) has announced the addition of Global Markets Direct's new report " Collagens Clinical Trial Analysis : " to their offering.

Summary


Global Markets Direct's "Collagens Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Collagens manufacturers, globally. The report provides exhaustive

information on each clinical investigation study with detailed coverage on the pipeline products these trials are being carried out for.

Scope



- The report provides analysis and review of the key clinical trials being carried out globally and across key Collagens market categories - Collagens
- The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc.


- The report provides an in-depth analysis of the clinical trials with information on trial phase, trial status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy



- Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.


- Stay ahead of the information curve in the fast changing Collagens market.


- Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.


- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.


- Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.


- Stay ahead of competition by understanding the changing competitive landscape in specific geographies.



Key Topics Covered:

- Executive Summary
- Collagens Clinical Trials
- Collagens Clinical Trial By Equipment Type
- Collagens Clinical Trials By Trial Phase and Trial Status
- Collagens Pipeline Products By Development Stage
- Collagens Pipeline Products By Therapy Area
- Collagens Collatamp G
- A Randomized, Controlled, Phase 3 Study of Gentamicin-Collagen Sponge (Collatamp G) in General Surgical Subjects at Higher Risk for Surgical Wound Infection
- A Randomized, Controlled, Phase 3 Study of Gentamicin-Collagen Sponge (Collatamp G) in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Infection
- A Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge (Collatamp G) Compared to Levofloxacin in Diabetic Patients With a Mild Infection of a Lower Extremity Skin Ulcer
- A Phase II, Randomized, Parallel, Double-Blind, Placebo-Controlled Study to Assess Prevention of Infection Using a Topical Gentamicin-Collagen Sponge (Collatamp G) in Diabetic Patients With Uninfected Lower Extremity Skin Ulcers
- A Randomized, Controlled, Open Label Study of the Safety and Efficacy of a Topical Gentamicin Collagen Sponge Combined With An Antibiotic Compared to Antibiotic Therapy Alone in Diabetic Patients With Moderately Infected Foot Ulcers
- Recent Developments
- Product News
- Mar 31, 2009: Innocoll Announces Submission Of 510 (k) Application For CollaRx Lidocaine Sponge
- Oct 17, 2007: TEI Biosciences Introduces Collagen Matrix For Soft Tissue Reconstruction
- Appendix


List of Tables



- Table 1: Collagens Clinical Trial By Equipment Type
- Table 2: Collagens Clinical Trials By Trial Phase and Trial Status
- Table 3: Collagens Pipeline Products By Development Stage
- Table 4: Collagens Pipeline Products By Therapy Area
- Table 5: Collatamp G - A Randomized, Controlled, Phase 3 Study of Gentamicin-Collagen Sponge (Collatamp G) in General Surgical Subjects at Higher Risk for Surgical Wound Infection
- Table 6: Collatamp G - A Randomized, Controlled, Phase 3 Study of Gentamicin-Collagen Sponge (Collatamp G) in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Infection
- Table 7: Collatamp G - A Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge (Collatamp G) Compared to Levofloxacin in Diabetic Patients With a Mild Infection of a Lower Extremity Skin Ulcer
- Table 8: Collatamp G - A Phase II, Randomized, Parallel, Double-Blind, Placebo-Controlled Study to Assess Prevention of Infection Using a Topical Gentamicin-Collagen Sponge (Collatamp G) in Diabetic Patients With Uninfected Lower Extremity Skin Ulcers
- Table 9: Collatamp G - A Randomized, Controlled, Open Label Study of the Safety and Efficacy of a Topical Gentamicin Collagen Sponge Combined With An Antibiotic Compared to Antibiotic Therapy Alone in Diabetic Patients With Moderately Infected Foot Ulcers


For more information visit www.researchandmarkets.com/research/049a01/collagens_clinical :



Research and MarketsLaura WoodSenior Manager press@researchandmarkets.com : mailto:press@researchandmarkets.com Fax

from USA: 646-607-1907Fax from rest of the world: +353-1-481-1716